Thomas Tensorer
Montigny-sur-loing, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Combined 20-Hydroxyecdysone and Antisense-Mediated Exon Skipping Improve Functional Outcomes in a Mouse Model of Duchenne Muscular Dystrophy.
Journal: Nucleic acid therapeutics
Published: February 17, 2025
Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice.
Journal: International journal of molecular sciences
Published: January 13, 2025
Impact of the Inhibition of Organic Anion Transporter on Tricyclo-DNA-Mediated Exon Skipping in the mdx Mouse Model.
Journal: Nucleic acid therapeutics
Published: November 15, 2023
Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model.
Journal: Biomedicines
Published: September 19, 2023
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 03, 2023
Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice.
Journal: Molecular therapy. Nucleic acids
Published: October 20, 2022
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice.
Journal: Molecular therapy. Nucleic acids
Published: August 04, 2022
Partial Restoration of Brain Dystrophin and Behavioral Deficits by Exon Skipping in the Muscular Dystrophy X-Linked (mdx) Mouse.
Journal: Annals of neurology
Published: December 15, 2021
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Journal: Nucleic acids research
Published: August 30, 2021
Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy.
Journal: Molecular therapy. Nucleic acids
Published: August 02, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026